PerkinElmer to Market Transgenomic Oncology Diagnostics Outside US | GenomeWeb

NEW YORK (GenomeWeb News) – Personalized medicine firm Transgenomic today announced that it has signed a deal under which PerkinElmer will market and distribute its portfolio of molecular diagnostic oncology products in all markets outside the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.